- Report
- August 2026
- 182 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- August 2026
- 188 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- January 2026
- 188 Pages
Global
From €3184EUR$3,545USD£2,720GBP
€3538EUR$3,939USD£3,022GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- August 2026
- 373 Pages
Global
From €5254EUR$5,850USD£4,488GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- February 2026
- 250 Pages
Global
From €4033EUR$4,490USD£3,445GBP
- Report
- May 2026
- 180 Pages
Global
From €4042EUR$4,500USD£3,453GBP
- Report
- December 2025
- 200 Pages
Global
From €7140EUR$7,950USD£6,099GBP
- Report
- May 2026
- 150 Pages
Global
From €2424EUR$2,699USD£2,071GBP
- Report
- May 2026
- 140 Pages
Global
From €2694EUR$2,999USD£2,301GBP
€3592EUR$3,999USD£3,068GBP
- Report
- January 2026
- 141 Pages
Global
From €3548EUR$3,950USD£3,031GBP
- Report
- October 2025
- 150 Pages
Global
From €4356EUR$4,850USD£3,721GBP
- Report
- August 2026
- 50 Pages
Global
From €2380EUR$2,650USD£2,033GBP
- Report
- November 2025
- 193 Pages
Global
From €4446EUR$4,950USD£3,798GBP
- Report
- November 2025
- 101 Pages
Global
From €3099EUR$3,450USD£2,647GBP

Voriconazole is an antifungal medication used to treat a variety of fungal infections, including those caused by Aspergillus and Candida species. It is a member of the triazole class of antifungal drugs, and is commonly used in the treatment of serious fungal infections in immunocompromised patients. Voriconazole is also used to treat infections caused by other fungi, such as Fusarium and Scedosporium species.
Voriconazole is available in both oral and intravenous formulations, and is generally well tolerated. Common side effects include visual disturbances, rash, and nausea. It is important to note that voriconazole can interact with other medications, and should be used with caution in patients with liver or kidney disease.
Voriconazole is a key player in the infectious diseases drugs market, and is used to treat a variety of fungal infections. It is an important treatment option for immunocompromised patients, and is generally well tolerated.
Some companies in the voriconazole market include Pfizer, Novartis, Merck, and Astellas Pharma. Show Less Read more